Adrenal News

Although nonfunctioning adrenal tumors and adenomas that cause mild autonomous cortisol excess were not associated with significant tumor changes in size or hormonal function, these benign tumors may increase risk for cardiometabolic comorbidities, according to study results published in the Annals of Internal Medicine.

Endocrine Today has compiled a list of the top five news reports with expert perspectives posted in May. Healio.com/Endocrinology readers were interested in a drop in diabetes incidence, an increase in pediatric DKA cases, benefits of bariatric surgery for teens, and more.

Endocrine Today has compiled a list of the top 10 news reports posted from meeting news coverage during the first few months of 2019.

A radioactive diagnostic agent for PET imaging effectively localized primary tumors or metastases in most adults with ectopic Cushing’s syndrome, leading to changes in clinical management for 64% of patients, according to findings from a retrospective study published in Clinical Endocrinology.

The aromatase inhibitor anastrozole effectively slowed bone age advancement in children with congenital adrenal hyperplasia during 5 years of treatment without changes in bone mineral density or body composition, suggesting the therapy could serve as a useful add-on therapy to glucocorticoid replacement, according to findings published in Clinical Endocrinology.

Endocrine Today has compiled a list of the top five news stories posted from the American Association of Clinical Endocrinologists Scientific & Clinical Congress, held April 24-28, 2019, in Los Angeles.

In this video exclusive, Endocrine Today Editorial Board Member Maria Fleseriu, MD, FACE, professor of neurological surgery and professor of medicine in the division of endocrinology, diabetes and clinical nutrition in the School of Medicine at Oregon Health & Science University and director of the OHSU Northwest Pituitary Center, discusses why mild Cushing’s syndrome matters.

In this video exclusive, Susan Samson, MD, PhD, FRCPC, FACE, associate professor in the department of endocrinology, diabetes and metabolism at Baylor College of Medicine in Houston and program chair for the American Association of Clinical Endocrinologists annual meeting describes highlights of this year’s sessions.

Endocrine Today has compiled a list of recent FDA news stories relating to endocrine practice. Drugs under consideration included those for osteoporosis, diabetes, overweight and obesity, hypoactive sexual desire disorder and hypogonadism.

Only 4.8% of patients with adrenal insufficiency who use medical identification jewelry clearly indicate on their emblem the need for urgent parenteral hydrocortisone in the event of an adrenal crisis, potentially jeopardizing the ability to receive proper assistance in an emergency, according to a cross-sectional analysis published in Clinical Endocrinology.